B. Braun Recalls Streamline Bloodline Sets for Dialog+ Over Risk of Leaks and Air Ingress
The US Food and Drug Administration has published an alert regarding a voluntary recall by B. Braun Medical Inc. involving specific lots of the Streamline Bloodline Set for Dialog+. A manufacturing failure where a solvent application step was omitted during assembly caused inadequate bonding of the dialyzer connector.
Due to the defective connection, the arterial tubing may detach, partially separate, or leak during priming or dialysis sessions. These failures present risks of significant extracorporeal blood loss, clotting and occlusion of the blood circuit, and air ingress, which in rare instances could bypass machine detection systems and lead to air embolism.
Healthcare facilities and distributors holding the affected devices are instructed to inform relevant staff, stop using the affected lots immediately, place them in quarantine, and arrange their return to the manufacturer. As of October 10, 2026, no serious injuries or fatalities had been reported.
Key points
- The recall affects B. Braun Streamline Bloodline Set for Dialog+ model SL-2010M2096 across lots A2600099, A2600128, and A2600136.
- An omitted solvent bonding step during assembly causes dialyzer connectors to leak or detach.
- Potential complications include extracorporeal blood loss, circuit clotting, treatment interruption, and air ingress.
- Facilities must immediately quarantine and discontinue the use of affected lots and return them to the supplier.
- No serious injuries or deaths had been reported related to this issue as of October 10, 2026.
What it means for you
Dialysis units and biomedical engineering teams in Pakistan should check their inventory for the impacted B. Braun model and lot numbers. Any affected units must be quarantined immediately to prevent potential blood loss or circuit complications, and local guidance should be verified through DRAP or authorized distributors.
Early Alert: B. Braun Medical Inc. Removes Streamline Bloodline Set for Dialog+
Summarised automatically from the official announcement. For educational purposes only — check the original source before making clinical decisions.